Protection against maternal infection-associated fetal growth restriction: Proof-of-concept with a microbial-derived immunomodulator

Mucosal Immunology

Volumn 10, Issue 3, 2017, Pages 789-801

  Scott, N M ^a   Lauzon Joset, J F ^a   Jones, A C ^a   Mincham, K T ^a   Troy, N M ^a   Leffler, J ^a   Serralha, M ^a   Prescott, S L ^a,b   Robertson, S A ^c   Pasquali, C ^d   Bosco, A ^a   Holt, P G ^a   Strickland, D H ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

^d Vifor (International) Inc   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CD40 ANTIGEN; CD45 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOMODULATING AGENT; INTERLEUKIN 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MICROBIAL PRODUCTS NOT CLASSIFIED ELSEWHERE; MONOCYTE CHEMOTACTIC PROTEIN 1; OM 85; PLACEBO; RANTES; TRANSCRIPTOME; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; AUTACOID; BACTERIAL ANTIGEN; IMMUNOLOGIC FACTOR; LIPOPOLYSACCHARIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; DOSE RESPONSE; DRUG MECHANISM; DRUG SAFETY; FEMALE; FETAL SURVIVAL; FETAL WEIGHT LOSS; HIGH RISK POPULATION; HOMEOSTASIS; IMMUNOCOMPETENT CELL; IMMUNOLOGICAL HOMEOSTASIS; IMMUNOMODULATION; INFECTION; INFECTION PREVENTION; INFLAMMATORY STRESS; INFLUENZA A (H1N1); INTRAUTERINE GROWTH RETARDATION; LUNG HOMOGENATE; LUNG LAVAGE; MATERNAL DISEASE; MATERNAL INFECTION; MOUSE; MYELOID-DERIVED SUPPRESSOR CELL; NONHUMAN; PARAAORTIC LYMPH NODE; PARAMETERS CONCERNING THE FETUS, NEWBORN AND PREGNANCY; PHENOTYPE; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; RISK REDUCTION; RNA SEQUENCE; STRESS; SURVIVAL; TRANSCRIPTOMICS; UPREGULATION; VIRAL CLEARANCE; VIRUS LOAD; WEIGHT REDUCTION; ANIMAL; BACTERIAL INFECTION; BAGG ALBINO MOUSE; COMPLICATION; DISEASE MODEL; DOWN REGULATION; FETUS DEVELOPMENT; HUMAN; IMMUNOLOGY; INFLUENZA A VIRUS; MALE; METABOLISM; ORTHOMYXOVIRUS INFECTION; PREGNANCY; PRENATAL EXPOSURE; PREVENTION AND CONTROL; PROOF OF CONCEPT; SPONTANEOUS ABORTION;

ABORTION, SPONTANEOUS; ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL INFECTIONS; DISEASE MODELS, ANIMAL; DOWN-REGULATION; FEMALE; FETAL DEVELOPMENT; HUMANS; IMMUNOLOGIC FACTORS; INFLAMMATION MEDIATORS; INFLUENZA A VIRUS; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED BALB C; ORTHOMYXOVIRIDAE INFECTIONS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PROOF OF CONCEPT STUDY;

EID: 85019967511     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2016.85     Document Type: Article

References (59)

1. Lapinsky, S.E. Obstetric infections. Crit. Care Clin. 29, 509-520 (2013).
2. Sappenfield, E., Jamieson, D.J. & Kourtis, A.P. Pregnancy and susceptibility to infectious diseases. Infect. Dis. Obstet. Gynecol. 2013, 752852 (2013).
3. Kemp, M.W. Preterm birth, intrauterine infection, and fetal inflammation. Front. Immunol. 5, 574 (2014).
4. Romero, R., Dey, S.K. & Fisher, S.J. Preterm labor: one syndrome, many causes. Science 345, 760-765 (2014).
5. Arck, P.C. & Hecher, K. Fetomaternal immune cross-talk and its consequences for maternal and offspring's health. Nat. Med. 19, 548-556 (2013).
6. Barker, D.J. & Thornburg, K.L. The obstetric origins of health for a lifetime. Clin. Obstet. Gynecol. 56, 511-519 (2013).
7. Meijer,W.J., van Noortwijk, A.G., Bruinse, H.W. & Wensing, A.M. Influenza virus infection in pregnancy: a review. Acta Obstet. Gynecol. Scand. 94, 797-819 (2015).
8. Luan, H. et al. OM85-BV induced the productions of IL-1beta, IL-6, and TNF-alpha via TLR4-and TLR2-mediated ERK1/2/NF-kappaB pathway in RAW264.7 cells. J. Interferon Cytokine Res. 34, 526-536 (2014).
9. Parola, C. et al. Selective activation of human dendritic cells by OM-85 through a NF-kB and MAPK dependent pathway. PLoS One 8, e82867 (2013).
10. Schaad, U.B. OM-85 BV, an immunostimulant in pediatric recurrent respiratory tract infections: a systematic review. World J. Pediatr. 6, 5-12 (2010).
11. Weinberger, M. Can we prevent exacerbations of asthma caused by common cold viruses. J. Allergy Clin. Immunol. 126, 770-771 (2010).
12. Emmerich, B., Emslander, H.P., Pachmann, K., Hallek, M., Milatovic, D. & Busch, R. Local immunity in patients with chronic bronchitis and the effects of a bacterial extract, Broncho-Vaxom, on T lymphocytes, macrophages, gamma-interferon and secretory immunoglobulin A in bronchoalveolar lavage fluid and other variables. Respiration 57, 90-99 (1990).
13. Collet, J.P. et al. Stimulation of nonspecific immunity to reduce the risk of recurrent infections in children attending day-care centers. The Epicreche Research Group. Pediatr. Infect. Dis. J. 12, 648-652 (1993).
14. Razi, C.H. et al. The immunostimulant OM-85 BV prevents wheezing attacks in preschool children. J. Allergy Clin. Immunol. 126, 763-769 (2010).
15. Soler, M., Mutterlein, R. & Cozma, G. Double-blind study of OM-85 in patients with chronic bronchitis or mild chronic obstructive pulmonary disease. Respiration 74, 26-32 (2007).
16. Strickland, D.H. et al. Persistent and compartmentalised disruption of dendritic cell subpopulations in the lung following influenza A virus infection. PLoS One 9, e111520 (2014).
17. Raj, R.S., Bonney, E.A. & Phillippe, M. Influenza, immune system, and pregnancy. Reprod. Sci. 21, 1434-1451 (2014).
18. Rasmussen, S.A., Jamieson, D.J. & Uyeki, T.M. Effects of influenza on pregnant women and infants. Am. J. Obstet. Gynecol. 207 (3 Suppl), S3-S8 (2012).
19. Le , S., Josse, J. & Husson, F. FactoMineR: an R package for multivariate analysis 25, 18 (2008).
20. Nadeau-Vallee, M. et al. Novel noncompetitive IL-1 receptor-biased ligand prevents infection-and inflammation-induced preterm birth. J. Immunol. 195, 3402-3415 (2015).
21. Robertson, S.A., Skinner, R.J. & Care, A.S. Essential role for IL-10 in resistance to lipopolysaccharide-induced preterm labor in mice. J. Immunol. 177, 4888-4896 (2006).
22. Cappelletti, M., Della Bella, S., Ferrazzi, E., Mavilio, D. & Divanovic, S. Inflammation and preterm birth. J. Leukoc. Biol. 99, 67-78 (2016).
23. Erlebacher, A. Immunology of the maternal-fetal interface. Annu. Rev. Immunol. 31, 387-411 (2013).
24. Robertson, S.A., Petroff, M.G. & Hunt, J.S. Immunology of pregnancy. In: Knobil and Neill's Physiology of Reproduction, 4th edn (Plant, T.M., Zeleznik, A.J., eds) 1835-1874 (Elsevier, Oxford, UK, 2015).
25. Tagliani, E. & Erlebacher, A. Dendritic cell function at the maternal-fetal interface. Expert Rev. Clin. Immunol. 7, 593-602 (2011).
26. Zhao, H., Kalish, F., Schulz, S., Yang, Y., Wong, R.J. & Stevenson, D.K. Unique roles of infiltrating myeloid cells in the murine uterus during early to midpregnancy. J. Immunol. 194, 3713-3722 (2015).
27. Collins,M.K., Tay, C.S. & Erlebacher, A. Dendritic cell entrapment within the pregnant uterus inhibits immune surveillance of the maternal/fetal interface in mice. J. Clin. Invest. 119, 2062-2073 (2009).
28. Bosco, A., McKenna, K.L., Firth, M.J., Sly, P.D. & Holt, P.G. A network modeling approach to analysis of the Th2 memory responses underlying human atopic disease. J. Immunol. 182, 6011-6021 (2009).
29. Langfelder, P. & Horvath, S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 9, 559 (2008).
30. Krä mer, A., Green, J., Pollard, J. Jr & Tugendreich, S. Causal analysis approaches in ingenuity pathway analysis. Bioinformatics 30, 523-530 (2014).
31. Pazos, M., Sperling, R.S., Moran, T.M. & Kraus, T.A. The influence of pregnancy on systemic immunity. Immunol. Res. 54, 254-261 (2012).
32. Levy, O. & Wynn, J.L. A prime time for trained immunity: innate immune memory in newborns and infants. Neonatology 105, 136-141 (2014).
33. Meissner, H.C. Viral bronchiolitis in children. N. Engl. J. Med. 374, 62-72 (2016).
34. Hacker, H. et al. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature 439, 204-207 (2006).
35. Kagan, J.C., Su, T., Horng, T., Chow, A., Akira, S. & Medzhitov, R. TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferonbeta. Nat. Immunol. 9, 361-368 (2008).
36. Parker, D. & Prince, A. Type I interferon response to extracellular bacteria in the airway epithelium. Trends Immunol. 32, 582-588 (2011).
37. Blank, V., Hirsch, E., Challis, J.R., Romero, R. & Lye, S.J. Cytokine signaling, inflammation, innate immunity and preterm labour-a workshop report. Placenta 29 (Suppl A), S102-S104 (2008).
38. Challis, J.R., Lockwood, C.J., Myatt, L., Norman, J.E., Strauss, J.F. 3rd & Petraglia, F. Inflammation and pregnancy. Reprod. Sci. 16, 206-215 (2009).
39. Husebye, H. et al. Endocytic pathways regulate Toll-like receptor 4 signaling and link innate and adaptive immunity. EMBO J. 25, 683-692 (2006).
40. van der Meer, J.W., Joosten, L.A., Riksen, N. & Netea, M.G. Trained immunity: a smart way to enhance innate immune defence. Mol. Immunol. 68, 40-44 (2015).
41. Kleinnijenhuis, J. et al. BCG-induced trained immunity in NK cells: role for non-specific protection to infection. Clin. Immunol. 155, 213-219 (2014).
42. von Mutius, E. & Radon, K. Living on a farm: impact on asthma induction and clinical course. Immunol. Allergy Clin. North Am. 28, 631-647 (2008).
43. von Mutius, E. The microbial environment and its influence on asthma prevention in early life. J. Allergy Clin. Immunol. 137, 680-689 (2016).
44. Jahnsen, F.L. et al. Accelerated antigen sampling and transport by airway mucosal dendritic cells following inhalation of a bacterial stimulusJ. Immunol. 177, 5861-5867 (2006).
45. Platt, A.M. & Randolph, G.J. Dendritic cell migration through the lymphatic vasculature to lymph nodes. Adv. Immunol. 120, 51-68 (2013).
46. Asselin-Paturel, C. et al. Type I interferon dependence of plasmacytoid dendritic cell activation and migration. J. Exp. Med. 201, 1157-1167 (2005).
47. Dai, J., Megjugorac, N.J., Amrute, S.B. & Fitzgerald-Bocarsly, P. Regulation of IFN regulatory factor-7 and IFN-alpha production by enveloped virus and lipopolysaccharide in human plasmacytoid dendritic cells. J. Immunol. 173, 1535-1548 (2004).
48. Amit, I. et al. Unbiased reconstruction of a mammalian transcriptional network mediating pathogen responses. Science 326, 257-263 (2009).
49. Bogdan, C., Mattner, J & Schleicher, U. The role of type I interferons in nonviral infections. Immunol. Rev. 202, 33-48 (2004).
50. Pasquali, C. et al. Enhanced mucosal antibody production and protection against respiratory infections following an orally administered bacterial extract. Front. Med. 1, 41 (2014).
51. Bizargity, P. & Bonney, E.A. Dendritic cells: a family portrait at midgestation. Immunology 126, 565-578 (2009).
52. Gomez-Lopez, N., Olson, D.M. & Robertson, S.A. Interleukin-6 controls uterine Th9 cells and CD8() T regulatory cells to accelerate parturition in mice. Immunol. Cell Biol. 94, 79-89 (2016).
53. Merad,M., Sathe,P.,Helft, J., Miller, J.&Mortha,A.The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu. Rev. Immunol. 31, 563-604 (2013).
54. Segura, E. & Amigorena, S. Inflammatory dendritic cells in mice and humans. Trends Immunol. 34, 440-445 (2013).
55. Diggins, K.E., Ferrell, P.B. Jr & Irish, J.M. Methods for discovery and characterization of cell subsets in high dimensional mass cytometry data. Methods 82, 55-63 (2015).
56. Kotecha,N., Krutzik, P.O. & Irish, J.M.Web-based analysis and publication of flow cytometry experiments. Curr. Protoc. Cytom. Chapter 10, Unit10.17 (2010).
57. Liao, Y., Smyth, G.K. & Shi, W. The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote. Nucleic Acids Res. 41, e108 (2013).
58. Anders, S. et al. Count-based differential expression analysis of RNA sequencing data using R and Bioconductor. Nat. Protoc. 8, 1765-1786 (2013).
59. Lynn, D.J. et al. InnateDB: facilitating systems-level analyses of the mammalian innate immune response. Mol. Syst. Biol. 4, 218 (2008).